Frequently Asked Questions Is tirzepatide a prescription medication in the Philippines
Jeffrey Flier, former Dean at Harvard Medical School, writes in STAT on How Pfizer ended up passing on my GLP-1 work back in the early 90s. Flier kicks off with Despite extremely promising results, Pfizer, the major funder of the work in alliance with California Biotechnology, abandoned the effort around 1991 after mistakenly concluding that the GLP-1 therapeutic approach was not worth continuing. He states that he is not trying to take credit for the GLP-1 market, rather that the story offers valuable lessons on drug development for pharmaceutical companies, researchers, and the general public alike. The article describes the early stages of drug development and testing from 1987, with Pfizer against an injectable GLP-1 version, and a focus on a way to deliver GLP-1 via transnasal, transcutaneous, or oral administration
MeAgain gives you that daily lens without replacing medical care, turning the work of protecting muscle and avoiding severe constipation into a playful routine with an adorable capybara that nudges protein, fiber, water, and exercise goals and a Journey Card to record milestones, so explore MeAgain if you want a clearer picture of how your body responds.
For All Vial Sizes Peptide Vials (Retatrutide): Choose your preferred vial size (5 mg, 10 mg, 20 mg, or 30 mg)
Promotes Lean Mass and Body Composition: Supports healthier body composition by encouraging fat-loss goals alongside lean mass support
